dc.contributor.author | Almeida, Gabriel Magno de Freitas | |
dc.contributor.author | Ravantti, Janne | |
dc.contributor.author | Grdzelishvili, Nino | |
dc.contributor.author | Kakabadze, Elene | |
dc.contributor.author | Bakuradze, Nata | |
dc.contributor.author | Javakhishvili, Elene | |
dc.contributor.author | Megremis, Spyridon | |
dc.contributor.author | Chanishvili, Nina | |
dc.contributor.author | Papadopoulos, Nikolaos | |
dc.contributor.author | Sundberg, Lotta-Riina | |
dc.date.accessioned | 2024-08-07T12:02:44Z | |
dc.date.available | 2024-08-07T12:02:44Z | |
dc.date.issued | 2024 | |
dc.identifier.citation | Almeida, G. M. D. F., Ravantti, J., Grdzelishvili, N., Kakabadze, E., Bakuradze, N., Javakhishvili, E., Megremis, S., Chanishvili, N., Papadopoulos, N., & Sundberg, L.-R. (2024). Relevance of the bacteriophage adherence to mucus model for Pseudomonas aeruginosa phages. <i>Microbiology Spectrum</i>, <i>Early online</i>. <a href="https://doi.org/10.1128/spectrum.03520-23" target="_blank">https://doi.org/10.1128/spectrum.03520-23</a> | |
dc.identifier.other | CONVID_220851185 | |
dc.identifier.uri | https://jyx.jyu.fi/handle/123456789/96547 | |
dc.description.abstract | Pseudomonas aeruginosa infections are getting increasingly serious as antimicrobial resistance spreads. Phage therapy may be a solution to the problem, especially if improved by current advances on phage-host studies. As a mucosal pathogen, we hypothesize that P. aeruginosa and its phages are linked to the bacteriophage adherence to mucus (BAM) model. This means that phage-host interactions could be influenced by mucin presence, impacting the success of phage infections on the P. aeruginosa host and consequently leading to the protection of the metazoan host. By using a group of four different phages, we tested three important phenotypes associated with the BAM model: phage binding to mucin, phage growth in mucin-exposed hosts, and the influence of mucin on CRISPR immunity of the bacterium. Three of the tested phages significantly bound to mucin, while two had improved growth rates in mucin-exposed hosts. Improved phage growth was likely the result of phage exploitation of mucin-induced physiological changes in the host. We could not detect CRISPR activity in our system but identified two putative anti-CRISPR proteins coded by the phage. Overall, the differential responses seen for the phages tested show that the same bacterial species can be targeted by mucosal-associated phages or by phages not affected by mucus presence. In conclusion, the BAM model is relevant for phage-bacterium interactions in P. aeruginosa, opening new possibilities to improve phage therapy against this important pathogen by considering mucosal interaction dynamics. | en |
dc.format.mimetype | application/pdf | |
dc.language.iso | eng | |
dc.publisher | American Society for Microbiology | |
dc.relation.ispartofseries | Microbiology Spectrum | |
dc.rights | CC BY 4.0 | |
dc.subject.other | bacteriophage | |
dc.subject.other | mucus | |
dc.subject.other | Pseudomonas | |
dc.subject.other | BAM model | |
dc.title | Relevance of the bacteriophage adherence to mucus model for Pseudomonas aeruginosa phages | |
dc.type | research article | |
dc.identifier.urn | URN:NBN:fi:jyu-202408075423 | |
dc.contributor.laitos | Bio- ja ympäristötieteiden laitos | fi |
dc.contributor.laitos | Department of Biological and Environmental Science | en |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | |
dc.type.coar | http://purl.org/coar/resource_type/c_2df8fbb1 | |
dc.description.reviewstatus | peerReviewed | |
dc.relation.issn | 2165-0497 | |
dc.relation.volume | Early online | |
dc.type.version | publishedVersion | |
dc.rights.copyright | © 2024 the Authors | |
dc.rights.accesslevel | openAccess | fi |
dc.type.publication | article | |
dc.relation.grantnumber | 314939 | |
dc.relation.grantnumber | 346772 | |
dc.subject.yso | limakalvot | |
dc.subject.yso | taudinaiheuttajat | |
dc.subject.yso | bakteerit | |
dc.subject.yso | antibioottiresistenssi | |
dc.subject.yso | fagiterapia | |
dc.subject.yso | bakteriofagit | |
dc.subject.yso | virukset | |
dc.subject.yso | patogeneesi | |
dc.format.content | fulltext | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p9294 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p8822 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p1749 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p29640 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p29496 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p25303 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p1123 | |
jyx.subject.uri | http://www.yso.fi/onto/yso/p22207 | |
dc.rights.url | https://creativecommons.org/licenses/by/4.0/ | |
dc.relation.doi | 10.1128/spectrum.03520-23 | |
dc.relation.funder | Research Council of Finland | en |
dc.relation.funder | Research Council of Finland | en |
dc.relation.funder | Suomen Akatemia | fi |
dc.relation.funder | Suomen Akatemia | fi |
jyx.fundingprogram | Academy Project, AoF | en |
jyx.fundingprogram | Academy Project, AoF | en |
jyx.fundingprogram | Akatemiahanke, SA | fi |
jyx.fundingprogram | Akatemiahanke, SA | fi |
jyx.fundinginformation | This study was funded by Academy of Finland (#314939 and #346992 for L.-R.S.) and the Centre for New Antibacterial Strategies (CANS) of the Arctic University of Norway (project ID #2520855 for G.M.D.F.A.). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 767015. | |
dc.type.okm | A1 | |